The last 3 decades have witnessed an unprecedented improvement in the outcome of patients with acute coronary syndromes. The widespread use of thrombolytic therapy and percutaneous coronary interventions, in association with increasingly potent antithrombotic agents, has contributed to significant reductions in mortality and morbidity in these patients.
Stunning, hibernation, and assessment of myocardial viability
2008
Abstract
The last 3 decades have witnessed an unprecedented improvement in the outcome of patients with acute coronary syndromes. The widespread use of thrombolytic therapy and percutaneous coronary interventions, in association with increasingly potent antithrombotic agents, has contributed to significant reductions in mortality and morbidity in these patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
prod_184796-doc_31786.pdf
non disponibili
Descrizione: Stunning hibernation viability
Dimensione
505.2 kB
Formato
Adobe PDF
|
505.2 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
